Top Markets
#1 Black Phoenix Black Phoenix +195.60%
#2 Islamic Coin Islamic Coin +158.06%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +34.69%
#5 Acurast Acurast +29.19%
#6 Cryptopia Cryptopia +21.79%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +17.72%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
#9 Playnance Playnance +13.33%
#10 wojak wojak +12.65%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rang in aandelen #41418
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2025-06-11
Marktkapitalisatie
$21.52K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Categorie

Healthcare
P/B-ratio voor Diagnocure, Inc. (DGCRF)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Diagnocure, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Diagnocure, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
STERIS plc STERIS plc
STERIS plc
STE.US
 3.1159 -
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
 - -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
 - -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
 - -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
 - -
CN